Advertisement

Topics

U.S. Supreme Court rejects Allergan bid to shield drug patents from review

10:38 EDT 15 Apr 2019 | Reuters

The U.S. Supreme Court on Monday cast aside pharmaceutical company Allergan Plc's unorthodox bid to shield patents from a federal administrative court's review by transferring them to a Native American tribe.

Original Article: U.S. Supreme Court rejects Allergan bid to shield drug patents from review

NEXT ARTICLE

More From BioPortfolio on "U.S. Supreme Court rejects Allergan bid to shield drug patents from review"

Advertisement
Quick Search
Advertisement
Advertisement